Silica as a Flow Agent: How It Improves Powder Flowability

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Is Silicon Dioxide Safe? What Science and Regulators Say
  • Keywords: silica supplier Thailand
  • Published: 2026-11-20 03:21:15
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
The pH in normal tissues under physiological conditions is typically neutral, while in solid tumors, the tumor microenvironment is normally slightly acidic due to the exuberant metabolism of tumor cells that results in the production of sizable amounts of lactic acid. 337, 338 Therefore, the construction of pH-responsive MSNs nanocarriers can attain targeted drug release and tumor therapy. Wagner et al. functionalized the external surface of MSNs by carboxylic groups, followed by attaching a stimuli-responsive capping system, that consists of a pH-responsive acetal linker and a biotin-avidin gatekeeper. 339 After uptaken by lysosome in tumor environment, the biotin-avidin caps were separated out and the immune-stimulant R848 (resiquimod) could be released, thus achieving improved targeted delivery of immune modulator to antigen-presenting cells. 339 Besides, in the construction of a light-responsive drug delivery system, Zhao et al. grafted the light-responsive azobenzene group on the surface of biodegradable MSNs, and β-cyclodextrin-modified polymer as the cap agent. In vitro experiments verified that the visible light triggered the isomerization of azobenzene, followed by the dissociation of CD-PMPC from MSNs surface and following drug release. The excellent anti-inflammatory effect of MSNs-based platform shown their potential in the treatment of osteoarthritis. 274 Regarding enzyme-responsive drug delivery system, some researchers reported the synthesis of MSNs attached with chitosan gatekeeper via azo bonds. The azo bonds could be cleaved by the colon-specific enzyme, leading to the separation of chitosan gatekeeper and the release of DOX. 334 In all, these functionalized MSNs-based drug delivery systems that specifically respond multiple stimulus signals provide a precisely localized and targeted way for illness treatments.

Nouryon Levasil: Colloidal Silica Product Range and Applications

Silica as an Abrasive: Hardness, Particle Size and Applications
Silica Whiteness: How It Is Measured and Why It Matters for Coatings and Rubber
The KIT-series was first reported by Ryoo's group at Korea Advanced Institute of Science and Technology (KAIST), 95 and the standard materials include KIT-1, KIT-5 and KIT-6. KIT-1 has disordered mesopores and amorphous pore walls, but its pore size is uniform and tunable, and it is more thermally stable than MCM-41. 95 In the meantime, KIT-5 and KIT-6 present well-ordered mesostructure with the space-group symmetry of Fm3̄m and Ia3̄d, respectively. 96, 97 Both the materials also have high particular surface areas, uniform pore size distribution and good stability, making them an excellent catalytic support. In addition, KIT-6 can be used to construct drug delivery systems for antimicrobial therapy, anti-tumor therapy and anti- blastocystosis therapy. 98, 99, 100
Hydrophobic Silica Powder: Properties, Water Repellency and Industrial Uses
Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61
Silicon Carbide vs Silica: Differences in Hardness, Structure and Uses
Rideau, E., Dimova, R., Schwille, P., Wurm, F. R. & Landfester, K. Liposomes and polymersomes: a comparative review towards cell mimicking. Chem. Soc. Rev. 47, 8572-8610 (2018). Article CAS PubMed Google Scholar

Silica Storage Conditions: How to Store Silica to Prevent Moisture and Caking

What is silica (SiO₂)?

silicon dioxide in supplements Huang, R. et al. Mesoporous silica nanoparticles: Facile surface functionalization and flexible biomedical applications in oncology. Acta Biomater. 116, 1-15 (2020). Article CAS PubMed Google Scholar

What is the difference between fumed silica and precipitated silica?

silica MSDS

What drives silica raw material prices?

silica aerogel Types of MSNs

Cite this article: Silica Raw Materials News. "Wood Coating Matting Agent: How to Achieve a Low-Gloss, Clear Finish ." Published 2026-11-20 03:21:15. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.